The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
GBA Biology and Therapies, 2018Molecular Imaging and Computer Typing in GBA-PD and Asymptomatic GBA-mutation Carriers
Study Rationale:
People who have a mutation in the GBA gene have a higher risk of developing Parkinson’s disease (PD) and, if they have PD, are more likely to have cognitive decline and dementia... -
LRRK2 LEAPS, 2018Link between LRRK2, Alpha-synuclein and Lysosomal Function Supplement
Study Rationale:
Our goal is to test whether people with Parkinson’s disease (PD) who carry a LRRK2 mutation (compared to those carrying another genetic PD-predisposing mutation or people with... -
Research Grant, 2018Genetic Factors that Influence Inherited Parkinson's Disease Associated with Changes in the GBA gene
Study Rationale:
Changes (variants) in the GBA gene are among the most common genetic factors that affect the risk of developing Parkinson's disease (PD). Individuals who carry the same GBA variants... -
Research Grant, 2018The Role of Lysosomal Proteins in Inherited Parkinson's Disease Associated with Changes in the GBA gene
Study Rationale:
Changes (mutations) in the GBA gene are among the most common and important genetic factors leading to Parkinson's disease (PD). The GBA gene directs the production of the... -
iPD Program, 2018Impact of Genetic Changes Linked to Both Crohn's Disease and Parkinson's Disease on the LRRK2 Protein
Study Rationale:
Recent research suggests an about 30 percent higher rate of Parkinson's disease (PD) in people with Crohn's disease (CD) than in those without CD. This could be, at least in part... -
Research Grant, 2018Nanoparticles for Detecting Parkinson's Disease Hallmarks with Magnetic Resonance Imaging
Study Rationale:
There is currently no effective imaging agent -- a chemical that reveals signs of disease -- that allows physicians to diagnose Parkinson's disease (PD) at an early stage, to monitor...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.